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Purpose: To report a case of Idiopathic retinal vasculitis, arteriolar macroaneurysms, and neuroretinitis (IRVAN). syndrome in a young female.
Case report: A 21-year-old woman presented with unilateral visual acuity (VA) loss. Ophthalmological examination disclosed unilateral optic
disc swelling, star-shaped macular exudation, multiple aneurysms surrounded by perivascular exudation, retinal vasculitis, and mild vitreous
reaction. The left eye examination was entirely normal. Clinical and paraclinical ﬁndings were compatible with IRVAN syndrome criteria. The
patient was treated with a short course of oral steroid, a trans-septal triamcinolone acetonide injection, selective laser photocoagulation in
peripheral non-perfusion areas, and intravitreal bevacizumab. In spite of primary good response, after each treatment cessation, VA dropped with
increasing central macular thickness (CMT), but response to intravitreal triamcinolone (4 mg/0.1 cc) was permanent and good.
Conclusion: IRVAN syndrome can have unilateral presentation. All treatment options were temporary except intravitreal steroid injection in our
case. The effect of steroid in IRVAN will need further evaluation.
& 2015 Iranian Society of Opthalmology. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Idiopathic reinal vasculitis, aneurysms, and neuroretinitis syndrome; IRVAN retina; UnilateralIntroduction
Idiopathic retinal vasculitis, arteriolar macroaneurysms, and
neuroretinitis (IRVAN) is a rare clinical entity that is usually
seen bilaterally in a young healthy female without any
systemic disease.1 The most complications of the disease are
because of exudation, which is caused by the macroaneurysms,
more common on the larger retinal arterioles and pre-retinal
neovascularization secondary to vasoproliferative complica-
tions because of peripheral capillary non-perfusion.1,2 The
suggested treatments are laser photocoagulation, surgery,
transscleral cryotherapy, steroids therapy, and administration
of monoclonal antibodies such as ranibizumab and inﬂixi-
mab.3,4 The diagnosis of disease is based on a combination of10.1016/j.joco.2015.10.006
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nder responsibility of the Iranian Society of Ophthalmology.clinical features. Three major criteria (retinal vasculitis, aneur-
ysmal dilations at arterial bifurcations, and neuroretinitis) and
three minor criteria (peripheral capillary non-perfusion, retinal
neovascularization, and macular exudation) have been deﬁned
for the diagnosis of the syndrome.3 Few cases of unilateral
IRVAN syndrome have been reported in literature, and in
other reports, it have started bilaterally or unilaterally with
some delay in involving the other eye.3–8 Herein, we report
clinical features, disease progression, and effects of treatment
in a case of unilateral IRVAN syndrome with typical ﬁndings.
Case report
A 21-year-old woman presented to our clinic with unilateral
visual acuity (VA) loss in her right eye gradually since several
months earlier. VA at presentation was 3/10 in the right eye
and 10/10 in her left eye. Anterior segment examination was
unremarkable, and intraocular pressure was within normallsevier B.V. This is an open access article under the CC BY-NC-ND license
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examination in her right eye. Posterior segment ﬁndings in her
right eye included unilateral optic disc swelling, star-shaped
macular exudation, multiple aneurysms surrounded by peri-
vascular exudation, retinal vasculitis, and mild vitreous reac-
tion. The left eye examination was entirely normal. Familial
history was negative.
Fluorescein angiography showed anuerysmal dilations and
hyperﬂuorescence of the vessels walls and leakage of the optic
disc in the late phases in the right eye and macroaneurysm
along the arterioles with late staining and signiﬁcant capillary
non-perfusion area with neovascular sheeting nearby. Neuror-
etinitis was diagnosed by blurred disc margin and late staining
of the optic nerve head and retinal vasculitis (Fig. 1).
An extensive medical evaluation was performed including a
chest X-ray, complete blood cell count (CBC diff), erythrocyte
sedimentation rate (ESR), C-reactive protein (CRP), urinalysis,
Venereal Disease Research Laboratory test (VDRL), ﬂuores-
cent treponemal antibody absorption test (FTA-ABS), puriﬁed
protein derivate (PPD test), C3, C4, anti-neutrophil cytoplas-
mic antibody (C-ANCA, P-ANCA), rheumatoid factor, human
immunodeﬁciency virus, antinuclear antibody, angiotensin
converting enzyme, and serum lysozyme. Systemic evaluation
and laboratory work-up did not suggest any systemic abnorm-
ality. Rheumatologic and neurologic consultation disclosed no
evidence of systemic vasculitis. Anterior chamber PCR results
were negative for cytomegalovirus (CMV), tuberculosis (TB),
herpes simplex virus (HSV), and varicella zoster virus (VZV)
infections.
Eye-tracked spectral-domain optical coherence tomography
(SD-OCT Heidelberg) was done from the posterior pole of
both eyes. There was diffuse retinal thickening at the posterior
pole, most severe at the level of the outer nuclear layer withFig. 1. Wide ﬁeld FAG of the right eye shows hyperﬂuorescence of the vessel
walls in the late phases and macroaneurysm along the arterioles with late
staining and signiﬁcant capillary non-perfusion area with neovascular sheeting
nearby in the right eye.schisis cavities and cystoid spaces and hyper-reﬂective excres-
cences in the outer retina with decay of the outer components
(Fig. 2).
According to all of clinical and paraclinical ﬁndings, the ﬁrst
diagnosis of IRVAN syndrome was made in this case. Our
patient had all of the three major (retinal vasculitis, aneurysmal
dilations at arterial bifurcations, and neuroretinitis) and 3 minor
(peripheral capillary non-perfusion, retinal neovascularization,
and macular exudation) criteria of disease in her right eye.
The patient was treated with a short course of oral steroid
therapy, a trans-septal triamcinolone acetonide injection, and
selective laser photocoagulation in peripheral non-perfusion
areas. After treatment, the visual acuity increased from 3/10 to
5/10, and central macular thickness (CMT) decreased during
the six-month follow-up. However, after treatment cessation,
VA dropped with increasing central macular thickness (CMT).
Intravitreal triamcinolone (4 mg/0.1 cc) was tried after poor
response to the primary treatment options, and this time, the
response to treatment was permanent and acceptable after six-
month follow-up. The VA remained 6/10, and the CMT
remained normal in control OCTs.
Discussion
Herein, we reported a unilateral IRVAN syndrome in a
young female. The diagnosis was based on the major and
minor criteria of disease, and because of atypical presentation,
we excluded other possible aetiologies by the means of
paraclinical exams and anterior chamber PCR.
Chang et al described the biggest series of this syndrome as
a condition that usually affects young, healthy females, and its
major features are multiple aneurysmal dilatations of the retinal
arteries, exudative retinopathy, diffuse staining of the optic
disc, and non-perfusion of peripheral capillaries.2 All of their
presented cases were bilateral or unilateral with secondary
involvement of the other eye in a period of time.
Unilateral and atypical IRVAN syndrome have been
reported in few case reports. Gedik et al in 2005 reported a
case of IRVAN. Based on their presentation, the patient's age,
the unilateral nature of her condition, and the hemorrhage from
the aneurysms that they observed were not typical features of
this disorder.6 Another unilateral IRVAN syndrome was
reported by Norlina et al, in which oral steroid combined with
a systemic immunosuppressant had no effect on the disease
course. They concluded that the unilaterality and unrespon-
siveness to systemic immunosuppressant can differentiate
IRVAN from systemic vasculitis although IRVAN is a
bilateral disease in nature.8
There is another report of atypical IRVAN syndrome
reported by Darly et al in which their patient demonstrated
the three major criteria of IRVAN: retinal vasculitis, aneur-
ysmal dilations at arterial bifurcations, and neuroretinitis.
However, their patient differs from a typical patient with
IRVAN in that he is male, is older than 50 years, and has a
probable associated systemic disease although his presentation
was also bilateral. Their report was the ﬁrst reported case of a
patient with both antiphospholipid syndrome and IRVAN.5
Fig. 2. Macular OCT of left eye shows increased retinal thickening at the posterior pole, with schisis cavities and cystoid spaces and hyper-reﬂective excrescences
in the outer retina with decay of the outer components.
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associated with positive perinuclear antineutrophil cytoplasmic
antibody (P-ANCA) which is an atypical association in this
case.7
Samuel et al divided the disease course into ﬁve stages.3
Stage 1 is macroaneurysms, exudation, neuroretinitis, and
retinal vasculitis. Stage 2 is capillary non-perfusion (angio-
graphic evidence). Stage 3 shows posterior segment neovas-
cularization of disc or elsewhere and/or vitreous hemorrhage.
In stage 4, there is anterior segment neovascularization
(rubeosis iridis), and stage 5 shows neovascular glaucoma.
Accordingly, our patient shows stage 2 of the disease.
As a rare retinal vascular condition, if IRVAN is left
untreated, it may lead to severe bilateral visual loss. Because
of the risk for sight-threatening complications, panretinal laser
photocoagulation, corticosteroids, and vitrectomy have been
used in an attempt to improve visual outcome, but most of
these treatments have remained controversial. Early panretinal
laser photocoagulation should be considered when angio-
graphic evidence of widespread retinal non-perfusion is pre-
sent and before (or shortly after) the development of
neovascularization. The value of corticosteroids in controlling
ischemic sequelae in IRVAN remains unproven.3
IRVAN syndrome is a diagnosis of exclusion, so we did an
extensive evaluation to rule out other etiologies. This evalua-
tion seems necessary especially in the atypical cases. For
example, anterior chamber sampling for PCR may have a high
rate of false negative results especially in the absence of AC
reaction, but the positive results are valuable.
Samuel et al reviewed the clinical features, disease progres-
sion, and effects of treatment on idiopathic retinitis, vasculitis,
aneurysms, and neuroretinitis. Treatments included panretinal
laser photocoagulation, cryotherapy, vitrectomy surgery, and
injection of periocular or intravitreal steroids, and a functional
staging system is proposed to improve treatment paradigms.3
Response to the oral and topical steroid was temporary in
our presented case in spite of intravitreal steroid injection. Wefollowed the patient for two years for evaluation of any
progression in the disease course and involvement of the other
eye. No sign of involvement of the other eye was observed
during this period of time. We think that this is enough to
consider our patient as a case with unilateral IRVAN
syndrome.
IRVAN syndrome can have unilateral presentation. Other
aetiologies should be ruled out by the means of paraclinical
examinations. Response to oral and topical steroid therapy and
photocoagulation was temporary in our case in spite of
intravitreal steroid injection.References
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